Viking Therapeutics Stock News & Updates

[WKN: A12GD6 | Symbol: VKTX]

Viking Therapeutics: Stock +25% - the next GLP-1 breakthrough? Monthly dose retains 90% of weight loss!

VK2735 retained up to 90% of the previously achieved weight loss with monthly maintenance dosing. ...

Viking Therapeutics: BTIG Confirms Buy Recommendation with Approximately 267% Price Potential!

In the current press releases from February 2026, Viking Therapeutics (VKTX) presents itself from a...

Viking Therapeutics: Canaccord sees 194% price potential referencing potential obesity drugs

Viking Therapeutics (VKTX) is a clinical-stage biopharmaceutical company focused on developing novel...

Viking Disappoints – Novo Nordisk Remains No. 1 in Oral Weight Loss Medications

The disappointing study data from Viking has confirmed it again: Novo Nordisk's oral Semaglutide tablet...

Stocks in Action USA: Oil-Dri, Viking Therapeutics, Groupon

Oil-Dri (ODC) – the sorbent manufacturer reports record results in the second quarter, pushing the...

  • 1